Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · Real-Time Price · USD
8.57
-0.13 (-1.49%)
Apr 29, 2026, 11:29 AM EDT - Market open
Kyverna Therapeutics Market Cap
Kyverna Therapeutics has a market cap or net worth of $518.74 million as of April 29, 2026. Its market cap has increased by 541.92% in one year.
Market Cap
518.74M
Enterprise Value
276.39M
1-Year Change
541.92%
Ranking
Category
Stock Price
$8.57
Market Cap Chart
Since the IPO on February 8, 2024, Kyverna Therapeutics's market cap has decreased from $898.10M to $518.74M, a decrease of -42.24%. That is a compound annual growth rate of -21.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 544.17M | 1.33% |
| Dec 31, 2025 | 537.02M | 232.60% |
| Dec 31, 2024 | 161.46M | -82.02% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ProKidney | 549.57M |
| Rigel Pharmaceuticals | 545.90M |
| Altimmune | 519.48M |
| AgomAb Therapeutics NV | 518.56M |
| Tectonic Therapeutic | 509.79M |
| Upstream Bio | 508.83M |
| MiMedx Group | 503.64M |
| Zura Bio | 500.02M |